Advertisement
Advertisement

SNOA

SNOA logo

Sonoma Pharmaceuticals, Inc. Common Stock

1.20
USD
Sponsored
+0.02
+1.69%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

1.15

-0.05
-4.50%

Sonoma Pharmaceuticals, Inc. Common Stock Profile

About

Sonoma Pharmaceuticals operates as a pharmaceutical company. It develops and markets solutions for the treatment of dermatological conditions, animal health and advanced tissue care. The company operates primarily in United States, Latin America and Europe. Sonoma Pharmaceuticals formerly known as Oculus Innovative Sciences and is headquatered in Petaluma, California.

Info & Links

CEO

Amy Trombly

Headquarters

5445 CONESTOGA COURT, SUITE 150
BOULDER, CO 80301, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.sonomapharma.com

Auditor

Frazier & Deeter, LLC

Share holders

61

Employees

8

Sonoma Pharmaceuticals, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

4.49M

Enterprise Value

1.93M

Enterprise Value/EBITDA(ttm)

-0.73

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

0.24

Price to Book(mrq)

1.19

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

38.23%

Operating Margin(ttm)

-9.42%

Profit Margin(ttm)

-19.99%

Return on Equity(ttm)

-42.56%

Return on Invested Capital(ttm)

-86.15%

Return on Assets(ttm)

-11.97%

Income Statement

Revenue(ttm)

17.72M

Revenue Per Share(ttm)

10.24

Gross Profit(ttm)

6.76M

EBITDA(ttm)3

-2.63M

Net Income Available to Common(ttm)

-3.37M

Diluted EPS(ttm)

-2.04

Share Statistics

Beta (5Y Monthly)

1.76

52-Week Change

-62.62%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

1.73M

Dividend Yield

0.00%

Float4

1.30M

% Held by Insiders

24.59%

% Held by Institutions

1.95%

Balance Sheet

Total Cash(mrq)

2.56M

Total Cash Per Share(mrq)

1.48

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.88%

Quick Ratio(mrq)

2.00%

Book Value Per Share(mrq)

1.98

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.99

Free Cash Flow(ytd)

-3.58M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement